(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

COMPLEXO POLIPEPTÍDICO ATIVÁVEL

ArquivadaInvention PatentPCT · US2022078157

Application data

Number

112024007316

Type

Invention Patent

Filing

10/14/2022

Publication

07/23/2024

PCT

US2022078157

Progress at the INPI

  1. Filing10/14/22
  2. Publication07/23/24
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 10/14/2022 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 01/06/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

AMGEN INC.

US

CYTOMX THERAPEUTICS, INC.

US

See this company's full portfolio

Inventors

E. F. (pessoa física)

US

J. S. (pessoa física)

US

L. B. (pessoa física)

US

M. P. (pessoa física)

US

R. B. (pessoa física)

US

S. M. (pessoa física)

US

W. K. (pessoa física)

US

Technical data

IPC Classification

Priority claims

US

63/256.410 · 10/15/2021

US

63/370.895 · 08/09/2022

Abstract

COMPLEXO POLIPEPTÍDICO ATIVÁVEL.A presente divulgação refere-se a complexos polipeptídicos biespecíficos heteromultiméricos (HBPCs) anti-EGFR, anti-CD3 ativável, e métodos de produção e uso dos mesmos.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

01/06/2026

RPI 2870

Arquivamento - Art. 33 da LPI

#11.1

10/21/2025

RPI 2859

Notificação de entrada na fase nacional - PCT

#1.3

07/23/2024

RPI 2794

Alteração de dados cadastrais

#1.1

04/24/2024

RPI 2781

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.